BRIEF-Cynapsus Therapeutics announces publication in journal Movement Disorders of data for treatment of OFF episodes in patients with parkinson's disease

Fri Aug 12, 2016 6:20am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Aug 12 (Reuters) - Cynapsus Therapeutics Inc :

* APL-130277 was safe and generally well-tolerated with no discontinuations because of adverse events

* Announces publication in journal Movement Disorders of data for treatment of OFF episodes in patients with parkinson's disease

* Results suggests APL-130277 rapidly and effectively converts patients from off to full on state Source text for Eikon: Further company coverage: